Published on
January 28, 2020
- 13:15 GMT
NAPIGEN Publication Provides Proof of Concept of its Technology for Editing Cytoplasmic Genome (Mitochondrial and Chloroplast ...
WILMINGTON, Del., Jan. 28, 2020 (GLOBE NEWSWIRE) -- NAPIGEN, a company developing proprietary technology to edit mitochondrial and chloroplast genomes, said it demonstrated for the first time the use of CRISPR technology and double-stranded DNA for genome …
Distribution channels:
Media, Advertising & PR, Technology
...
